propagermanium has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaka, M; Ehira, N; Fukushima, A; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Minami, H; Musashi, M; Obara, S; Ogura, N; Tanaka, J; Tsutsumi, Y; Yamato, H | 1 |
| Aoyama, S; Fukumoto, M; Inagaki, N; Lai, M; Nishimura, M; Oda, Y; Ohmoto, E; Takahashi, I; Takaoka, K; Ueda, I | 1 |
1 trial(s) available for propagermanium and Multiple Myeloma
| Article | Year |
|---|---|
Effectiveness of propagermanium treatment in multiple myeloma patients.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Germanium; Humans; Interferon Inducers; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Organometallic Compounds; Propionates; Remission Induction; Treatment Outcome | 2004 |
1 other study(ies) available for propagermanium and Multiple Myeloma
| Article | Year |
|---|---|
[Effects of interferon and its inducers on neutrophil chemiluminescence].
Topics: Adenocarcinoma; Adult; Aged; Female; Germanium; Humans; Interferon Inducers; Interferon Type I; Kidney Neoplasms; Leukemia, Myeloid; Luminescent Measurements; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutrophils; Organometallic Compounds; Oxygen Consumption; Phagocytosis; Propionates | 1984 |